Operator

Good morning, ladies and gentlemen, and welcome to The American Transplant Congress Data Update Call. [Operator Instructions]. This call is being recorded on Monday, June 22, 2026. I would now like to turn the conference over to Paul Little, Chief Financial Officer. Please go ahead.

Paul Little
Chief Financial Officer

Good morning, everyone, and thank you for joining our BESTOW Long-term data update conference call. I'm joined on today's call by David-Alexandre Gros, Chief Executive Officer, Steve Perrin, our President and Chief Scientific Officer; and David Hovland, our Chief Regulatory Officer.

Earlier today, Eledon issued a press release detailing the updated clinical results presented at the American Transplant Congress. You may access the release and this presentation under the Investors tab on our company's website at eledon.com.

I would like to remind everyone that statements made during the conference call relating to Eledon's expected future performance, future business plans, our future events or plans may include forward-looking statements as defined under the Private Securities Litigation Reform Act of 1995. All such forward-looking statements are intended to be subject to the safe harbor protection provided by the Reform Act. Actual outcomes and results could differ materially from these forecasts due to the impact of many factors beyond the control of Eledon. Eledon expressly